The Insider
Biotech Special Event
The Insider: Biotech Special Event session is an interactive panel discussion featuring industry leaders providing valuable insights on biotech investing basics, how the sector fits into the current market, investment trends and how to identify potential opportunities.
Matt McNamara
Horizon 3 Biotech
Steven Yatomi-Clarke
Prescient Therapeutics
Insights
Matt unravels why he believes investing in later-stage companies yields better results and Steven weighs in with his views on the role of technology in biotech. Also, learn what investors without biotech experience can expect from investing in the sector.
21st July, 2022
Matt explains how Horizon 3 Biotech’s ‘Achilles Heel’ investment approach and the company’s specialised team narrow down high-potential biotechs, and Steven talks about the challenges of investing in an ‘opaque’ industry with many price imperfections.
21st July, 2022
Patrick, Steven and Matt discuss current biotech investment trends, including which emerging segments and technologies are attracting the most investment capital, and mention an exciting inter-industry convergence with huge investment potential.
21st July, 2022
Like these investment ideas? Join our next session to discover more like this by clicking here
Steven explains how Prescient has set itself up to succeed in healthcare’s largest sector, the unique advantages of Prescient’s positioning in the industry and how the company’s technologies and business model complement its positioning.
21st July, 2022
Matt reveals five key stocks in Horizon 3 Biotech’s wholesale portfolio and provides rationale for why they fit into the fund’s investment philosophy. He also talks about the companies’ key advantages, target markets and how they are faring in the current market environment.
21st July, 2022
Meet the Fund Manager
Upcoming Session
Register for an Upcoming Webcast
This exclusive event gives investors unprecedented access to Australia’s leading fund managers to hear about their favourite companies, unique market insights, and the opportunity to ask questions.
This is a live and interactive online session, and participants are encouraged to ask questions. Spots are limited, so secure yours today.
Book into the next session
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.
Past Sessions
Martin Pretty Equitable Investors
Martin Pretty gained vast financial experience as an investment manager at Thorney Investment Group, helping deliver one of the group’s highest annualised three-year returns (18.2% per annum) as at February 2017. He is the director of several ASX-listed companies and as a financial journalist has contributed to the Australian Financial Review and other reputable publications.
Luke Winchester Merewether Capital
Luke Winchester, managing director and CIO at Merewether Capital, started the company with the goal of building a reputation as one of the leading small and microcap managers in the Australian equities market and is one of the largest investors in the Merewether Capital Inception Fund.
Harley Grosser Capital H Management
Harley Grosser, founder and managing director, founded Capital H Management in 2014 having previously worked for Pie Funds and Bligh Capital. He has been investing in ASX-listed small caps for 12 years and is also the managing director of Australian Rural Capital and non-executive director of Motio.